Early AMD associated with coronary heart disease

Article

The results of a study published in the July issue of Ophthalmology has discovered that people in the early stages of age-related macular degeneration (AMD) are at a higher risk of developing coronary heart disease (CHD), offering further support to the theory that AMD is associated with underlying systemic vascular disease.

The results of a study published in the July issue of Ophthalmology has discovered that people in the early stages of age-related macular degeneration (AMD) are at a higher risk of developing coronary heart disease (CHD), offering further support to the theory that AMD is associated with underlying systemic vascular disease.

Tien Yin Wong, MD from Singapore Eye Research Institute and international colleagues conducted a population-based prospective cohort study of 2,228 people free of stroke aged between 69 and 97 years of age, 1,786 of whom were also free of CHD.

Of those free of CHD, 303 developed incident CHD over a seven-year period. It was found that those with early-stage AMD (n=227) had a higher cumulative incidence of CHD than those without, 28.5% versus 18.9%. However, late-stage AMD (n=25) was not associated with incident CHD. Of the total 2,228 persons, 198 developed incident stroke but neither early or late-stage AMD was associated with incident stroke.

It was the conclusion of the authors that people with early-stage AMD do have a higher risk of developing coronary heart disease but not stroke.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.